These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21780101)

  • 1. P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma.
    Brambilla D; Zamboni S; Federici C; Lugini L; Lozupone F; De Milito A; Cecchetti S; Cianfriglia M; Fais S
    Int J Cancer; 2012 Jun; 130(12):2824-34. PubMed ID: 21780101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling.
    Lu Y; Li F; Xu T; Sun J
    Int J Mol Med; 2017 Apr; 39(4):993-1000. PubMed ID: 28260091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezrin and moesin expression in canine and feline osteosarcoma.
    Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
    Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
    Bodey B; Taylor CR; Siegel SE; Kaiser HE
    Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of an ezrin mutant defective in F-actin binding.
    Saleh HS; Merkel U; Geissler KJ; Sperka T; Sechi A; Breithaupt C; Morrison H
    J Mol Biol; 2009 Jan; 385(4):1015-31. PubMed ID: 19084535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance and malignancy in human osteosarcoma.
    Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
    Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trps1 is associated with the multidrug resistance of osteosarcoma by regulating MDR1 gene expression.
    Jia M; Hu J; Li W; Su P; Zhang H; Zhang X; Zhou G
    FEBS Lett; 2014 Mar; 588(5):801-10. PubMed ID: 24491996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
    Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
    Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance modification using pulsing electromagnetic field stimulation for multidrug resistant mouse osteosarcoma cell line.
    Hirata M; Kusuzaki K; Takeshita H; Hashiguchi S; Hirasawa Y; Ashihara T
    Anticancer Res; 2001; 21(1A):317-20. PubMed ID: 11299755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
    Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
    Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
    Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
    Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
    Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
    Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezrin promotes invasion and migration of the MG63 osteosarcoma cell.
    Zhang J; Zuo J; Lei M; Wu S; Zang X; Zhang C
    Chin Med J (Engl); 2014; 127(10):1954-9. PubMed ID: 24824262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box.
    Çelik H; Hong SH; Colón-López DD; Han J; Kont YS; Minas TZ; Swift M; Paige M; Glasgow E; Toretsky JA; Bosch J; Üren A
    Mol Cancer Ther; 2015 Nov; 14(11):2497-507. PubMed ID: 26358752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma.
    Cagliero E; Ferracini R; Morello E; Scotlandi K; Manara MC; Buracco P; Comandone A; Baroetto Parisi R; Baldini N
    Oncol Rep; 2004 Nov; 12(5):1023-31. PubMed ID: 15492788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein.
    Si M; Zhao J; Li X; Tian JG; Li YG; Li JM
    Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains.
    Radeva G; Perabo J; Sharom FJ
    FEBS J; 2005 Oct; 272(19):4924-37. PubMed ID: 16176266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.
    Yang X; Yang P; Shen J; Osaka E; Choy E; Cote G; Harmon D; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    Br J Cancer; 2014 Jun; 110(12):2896-904. PubMed ID: 24853187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.